Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Ashland reports $497 million third quarter sales and reaffirms outlook

None

Ashland (ASH) reported fiscal third-quarter 2026 sales of $497 million, up 7% from $463 million in the prior-year quarter. Net income was $16 million, or $0.35 per diluted share, compared with a net loss of $742 million a year earlier.

The company reaffirmed full-year fiscal 2026 sales guidance of $1.835 billion to $1.870 billion and adjusted EBITDA guidance of $385 million to $400 million.

  • Income from continuing operations was $41 million, or $0.89 per diluted share.
  • Sales volumes rose 6% from the prior-year quarter, with gains across all business units.
  • Cash flows provided by operating activities were $121 million, up from $114 million a year earlier.
  • Life Sciences sales rose 11% to $180 million, while Personal Care sales increased 5% to $155 million.
  • Specialty Additives sales increased 4% to $136 million, and Intermediates sales rose 12% to $37 million.

$ASH Hedge Fund Activity

We have seen 149 institutional investors add shares of $ASH stock to their portfolio, and 140 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles